BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 20006397)

  • 1. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
    Castéra L; Sebastiani G; Le Bail B; de Lédinghen V; Couzigou P; Alberti A
    J Hepatol; 2010 Feb; 52(2):191-8. PubMed ID: 20006397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.
    Sebastiani G; Halfon P; Castera L; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
    Aliment Pharmacol Ther; 2012 Jan; 35(1):92-104. PubMed ID: 22035045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
    Castéra L; Le Bail B; Roudot-Thoraval F; Bernard PH; Foucher J; Merrouche W; Couzigou P; de Lédinghen V
    J Hepatol; 2009 Jan; 50(1):59-68. PubMed ID: 19013661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
    Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
    HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.
    Stibbe KJ; Verveer C; Francke J; Hansen BE; Zondervan PE; Kuipers EJ; de Knegt RJ; van Vuuren AJ
    Scand J Gastroenterol; 2011 Jul; 46(7-8):962-72. PubMed ID: 21623677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis C.
    Rizzo L; Calvaruso V; Cacopardo B; Alessi N; Attanasio M; Petta S; Fatuzzo F; Montineri A; Mazzola A; L'abbate L; Nunnari G; Bronte F; Di Marco V; Craxì A; Cammà C
    Am J Gastroenterol; 2011 Dec; 106(12):2112-20. PubMed ID: 21971536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.
    Sebastiani G; Vario A; Guido M; Noventa F; Plebani M; Pistis R; Ferrari A; Alberti A
    J Hepatol; 2006 Apr; 44(4):686-93. PubMed ID: 16490278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C.
    Verveer C; Zondervan PE; ten Kate FJ; Hansen BE; Janssen HL; de Knegt RJ
    Liver Int; 2012 Apr; 32(4):622-8. PubMed ID: 22098684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
    Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.
    Boursier J; de Ledinghen V; Zarski JP; Fouchard-Hubert I; Gallois Y; Oberti F; Calès P;
    Hepatology; 2012 Jan; 55(1):58-67. PubMed ID: 21898504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
    Degos F; Perez P; Roche B; Mahmoudi A; Asselineau J; Voitot H; Bedossa P;
    J Hepatol; 2010 Dec; 53(6):1013-21. PubMed ID: 20850886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
    Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
    J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.
    Boursier J; Vergniol J; Sawadogo A; Dakka T; Michalak S; Gallois Y; Le Tallec V; Oberti F; Fouchard-Hubert I; Dib N; Rousselet MC; Konaté A; Amrani N; de Ledinghen V; Calès P
    Liver Int; 2009 Nov; 29(10):1507-15. PubMed ID: 19725892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients.
    Bourliere M; Penaranda G; Ouzan D; Renou C; Botta-Fridlund D; Tran A; Rosenthal E; Wartelle-Bladou C; Delasalle P; Oules V; Portal I; Castellani P; Lecomte L; Rosenthal-Allieri MA; Halfon P
    Aliment Pharmacol Ther; 2008 Aug; 28(4):458-67. PubMed ID: 18498446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM; Farid K; Emran TM; Attallah AA
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C.
    Cardoso AC; Carvalho-Filho RJ; Stern C; Dipumpo A; Giuily N; Ripault MP; Asselah T; Boyer N; Lada O; Castelnau C; Martinot-Peignoux M; Valla DC; Bedossa P; Marcellin P
    Liver Int; 2012 Apr; 32(4):612-21. PubMed ID: 22103765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation.
    Viganò M; Paggi S; Lampertico P; Fraquelli M; Massironi S; Ronchi G; Rigamonti C; Conte D; Colombo M
    Aliment Pharmacol Ther; 2011 Aug; 34(3):353-62. PubMed ID: 21631559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.
    Lesmana CR; Salim S; Hasan I; Sulaiman AS; Gani RA; Pakasi LS; Lesmana LA; Krisnuhoni E; Budihusodo U
    J Clin Pathol; 2011 Oct; 64(10):916-20. PubMed ID: 21670074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.